Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study

Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study

Background/Aims: Non-cardiac chest pain (NCCP) is defined as recurrent angina pectoris-like pain without evidence of coronary heart disease, and is usually related to esophageal diseases, such as gastroesophageal reflux disease (GERD). Proton pump inhibitors (PPIs) are important for diagnosis and tr...

Full description

Bibliographic Details
Main Authors: Jae Kyun Choi, Hyun Ik Shim, Cheol Min Shin, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2020-06-01
Series:The Korean Journal of Gastroenterology
Subjects:
non-cardiac chest pain
gastroesophageal reflux
proton pump inhibitors
esomeprazole
Online Access:http://www.kjg.or.kr/journal/view.html?uid=5586&vmd=Full

Similar Items

Similar Items